GOSEBRUCH HENRY O 1659625 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-09 | 2023-05-09 | 4 | Gosebruch Henry O | DIRECTOR | acq | 50000.0 | 100.0 | 18.0 | Direct | Common Stock | ACELYRIN, INC. | code P | 50000.0 | 0.0 (SLRN) | |
| 2023-09-14 | 2023-09-14 | 3 | Gosebruch Henry O | PRESIDENT & CEO | holding | 382345.0 | 0 | 0.0 | Direct | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-14 | 2023-09-14 | 3 | Gosebruch Henry O | PRESIDENT & CEO | holding | 127448.0 | 0 | 0.0 | Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-19 | 2023-09-19 | 4 | Gosebruch Henry O | PRESIDENT & CEO | holding | 382345.0 | 0 | 0.0 | Direct | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-19 | 2023-09-19 | 4 | Gosebruch Henry O | PRESIDENT & CEO | holding | 127448.0 | 0 | 0.0 | Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2023-09-19 | 2023-09-19 | 2023-09-19 | 4 | Gosebruch Henry O | PRESIDENT & CEO | acq | 15000.0 | 100.0 | 12.62 | Hg4 Kyc Trust | Common Stock | NEUMORA THERAPEUTICS, INC. | code P | 15000.0 | 0.0 (NMRA) | |
| 2024-02-16 | 2024-02-14 | 4 | Gosebruch Henry O | PRESIDENT & CEO | holding | 127448.0 | 0 | 8.35 | 0.0 | Lu Leng Felicia Chua Descendants 2012 Irrevocable Trust | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 152.7 (NMRA) | ||
| 2024-02-16 | 2024-02-14 | 4 | Gosebruch Henry O | PRESIDENT & CEO | holding | 15000.0 | 0 | 0.98 | 0.0 | Hg4 Kyc Trust | Common Stock | NEUMORA THERAPEUTICS, INC. | NA | 152.7 (NMRA) | ||
| 2024-02-16 | 2024-02-14 | 2024-02-14 | 4 | Gosebruch Henry O | PRESIDENT & CEO | acq | 80000.0 | 17.3 | 5.24 | 0.0 | Direct | Common Stock | NEUMORA THERAPEUTICS, INC. | code A | 462345.0 | 152.7 (NMRA) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-09 | 2023-05-09 | 4 | Gosebruch Henry O | DIRECTOR | dsp | 155450.0 | 100.0 | 7.43 | Direct | Director Stock Option (Right To Buy) | ACELYRIN, INC. | code J | 0.0 | 0.0 (SLRN) | |
| 2023-05-11 | 2023-05-09 | 2023-05-09 | 4 | Gosebruch Henry O | DIRECTOR | acq | 155450.0 | 100.0 | 7.43 | Direct | Director Stock Option (Right To Buy) | ACELYRIN, INC. | code J | 155450.0 | 0.0 (SLRN) | |
| 2023-09-14 | 2023-09-14 | 3 | Gosebruch Henry O | PRESIDENT & CEO | holding | 2039177.0 | 0 | 6.36 | Direct | Stock Option (Right To Buy) | NEUMORA THERAPEUTICS, INC. | NA | 0.0 (NMRA) | |||
| 2024-02-16 | 2024-02-14 | 2024-02-14 | 4 | Gosebruch Henry O | PRESIDENT & CEO | acq | 160000.0 | 100.0 | 10.48 | 18.07 | Direct | Stock Option (Right To Buy) | NEUMORA THERAPEUTICS, INC. | code A | 160000.0 | 152.7 (NMRA) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)